This year's jab has a few tweaks, including changes to better combat the Super-K strain.

Sept 1 (Reuters) - GSK said on Tuesday it will advance its mRNA-based seasonal influenza vaccine candidate to a late-stage ...

The first mRNA-based flu shot to be approved by the Food and Drug Administration will be ready for the upcoming flu season. Moderna, the vaccine's maker ...

The Centers for Disease Control and Prevention recommends that everyone six months and older receive an annual flu shot. The ...

While previous administrations supported fall vaccine pushes, the Trump administration is shying away from a public health ...

For older adults, the flu vaccine could look a little different this year.

The Food and Drug Administration on Wednesday approved the U.S.’s first flu shot that uses mRNA technology: mFlusiva, from drugmaker Moderna.

It doesn’t always receive the same attention as the flu, COVID-19, RSV or measles, but pneumonia can be serious and even life ...

The flu vaccine roll-out has begun, with millions of children and pregnant women across England eligible to receive the jab ...

NHS begins super flu vaccine rollout for 2026/27 season. Pregnant women eligible from September 1, other adults from October 1. Fee uplifts confirmed. TSR ...